Zura Bio
Lindsey McClelland is a seasoned professional in the biopharmaceutical industry, currently serving as Head of People and Culture at Zura Bio Limited since March 2024. Previously, McClelland held various key roles at Oxeia Biopharmaceuticals Inc, including Vice President of Operations and Director of Program Management. Additional experience includes consulting in project management and operations at OneBiopharma, and managing technical operations administration at EPIRUS Biopharmaceuticals. Early career accomplishments feature a position as a Medical Writing Assistant at Vertex Pharmaceuticals and editorial roles at Interweave. Lindsey McClelland holds a Bachelor of Arts degree in History from Boston College.
This person is not in any teams
This person is not in any offices
Zura Bio
1 followers
Zura Bio is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders. Currently, Zura Bio is developing three assets which have completed phase 1/1b studies and are Phase 2 ready. The company is developing a portfolio of therapeutic indications for tibulizumab (ZB-106), torudokimab (ZB-880), and ZB-168 with a goal of demonstrating their efficacy, safety, and dosing convenience in immune and inflammatory disorders. Zura Bio is headquartered in Henderson, NV with team members in the UK and USA.